COMPANY DESCRIPTION
Acoustic MedSystems, Inc. (AMS) business focuses on image-guided minimally and non-invasive therapeutic ultrasound devices for treatment of localized soft tissue diseases and pain.
From inception to date, grants from the National Institutes of Health, and the National Science Foundation have provided funds to develop and optimize AMS’ ultrasonic precision surgical ablation technology. Complementing these sources of capital has been contract work and private capital. AMS continues its R&D under competitive NIH support. Manufacturing processes are ISO 13485 compliant. AMS operates in a facility in Savoy, IL, just south of the University of Illinois (UIUC) campus.
PRODUCT
AMS developed the TheraVision® ablation surgery system and ACOUSTx® ultrasound treatment devices. Together, they constitute a treatment planning and image-guided ablative therapy system capable of providing superior treatment for tumors as well as benign diseases. The ultrasound treatment devices are proprietary single-use needles and catheters for delivering therapy conformable and customized to the individual patient. This system is FDA 510(k) cleared for clinical use.
TheraVision® provides
ACOUSTx® treatment device
CONTACT US
info@acousticmed.com
+1 217 239-0900
www.acousticmed.com
Savoy, IL 61874
E. Clif Burdette, PhD, CEO